These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35593250)

  • 21. Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival.
    Thanasitthichai S; Prasitthipayong A; Boonmark K; Purisa W; Guayraksa K
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3101-3106. PubMed ID: 31653160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
    Nogues X; Servitja S; Peña MJ; Prieto-Alhambra D; Nadal R; Mellibovsky L; Albanell J; Diez-Perez A; Tusquets I
    Maturitas; 2010 Jul; 66(3):291-7. PubMed ID: 20399042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and Mammographic Findings.
    Riedel J; Straub L; Wissing J; Artmann A; Schmidmayr M; Kiechle M; Seifert-Klauss VR
    Geburtshilfe Frauenheilkd; 2016 May; 76(5):570-578. PubMed ID: 27239067
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study.
    Shin J; Lee JE; Ko HY; Nguyen TL; Nam SJ; Hopper JL; Song YM
    Eur J Cancer Prev; 2018 May; 27(3):239-247. PubMed ID: 28957821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic Density and Vitamin D Levels - A Cross-sectional Study.
    Straub L; Riedel J; Luppa PB; Wissing J; Artmann A; Kiechle M; Seifert-Klauss VR
    Geburtshilfe Frauenheilkd; 2017 Mar; 77(3):257-267. PubMed ID: 28392579
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing Biomarkers of Breast Cancer Risk in Underserved Women in a Midwestern County.
    DeWitt MA; Croghan IT; Vachon CM; Thacher TD; Venegas Pont MR; Neal L; Stan DL; Jenkins SM; Pruthi S
    J Prim Care Community Health; 2021; 12():21501327211017792. PubMed ID: 34009069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.
    Crew KD; Shane E; Cremers S; McMahon DJ; Irani D; Hershman DL
    J Clin Oncol; 2009 May; 27(13):2151-6. PubMed ID: 19349547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
    Yao S; Sucheston LE; Millen AE; Johnson CS; Trump DL; Nesline MK; Davis W; Hong CC; McCann SE; Hwang H; Kulkarni S; Edge SB; O'Connor TL; Ambrosone CB
    PLoS One; 2011 Feb; 6(2):e17251. PubMed ID: 21386992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
    Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
    Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women.
    Fair AM; Lewis TJ; Sanderson M; Dupont WD; Fletcher S; Egan KM; Disher AC
    Nutr Res; 2015 Oct; 35(10):851-857. PubMed ID: 26321093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic density to predict response to neoadjuvant systemic breast cancer therapy.
    Di Cosimo S; Depretto C; Miceli R; Baili P; Ljevar S; Sant M; Cappelletti V; Folli S; Gennaro M; De Braud FG; Bianchi G; Vingiani A; Pruneri G; Marchianò A; La Rocca E; De Santis MC; Scaperrotta GP
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):775-781. PubMed ID: 35037102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis.
    Voutsadakis IA
    Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):16-26. PubMed ID: 33002425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors associated with mammographic breast density among women in Karachi Pakistan.
    Shamsi U; Afzal S; Shamsi A; Azam I; Callen D
    BMC Womens Health; 2021 Dec; 21(1):438. PubMed ID: 34972514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer.
    Sartor H; Zackrisson S; Elebro K; Hartman L; Borgquist S
    Cancer Causes Control; 2015 Jun; 26(6):931-9. PubMed ID: 25860114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.
    Ma H; Luo J; Press MF; Wang Y; Bernstein L; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):479-85. PubMed ID: 19190139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
    Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of serum 25 hydroxyvitamin D in breast cancer: An Indian scenario.
    Patel SR; Patel KD; Patel KR; Gokani RA; Patel JB; Patel PS; Shah FD
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105726. PubMed ID: 32682059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.
    Vashi PG; Lammersfeld CA; Braun DP; Gupta D
    Nutr J; 2011 May; 10():51. PubMed ID: 21575232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
    Buono G; Giuliano M; De Angelis C; Lauria R; Forestieri V; Pensabene M; Bruzzese D; De Placido S; Arpino G
    Clin Breast Cancer; 2017 Nov; 17(7):559-563. PubMed ID: 28601383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.